Log In
BCIQ
Print this Print this
 

Interleukin-6 (IL-6) receptor (CD126)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-6 (IL-6) receptor (CD126)

BCIQ
Print ChartPrint this
Marketed, 2 Registration, 1 Phase III, 1 Phase III, 3 Phase II, 1 Phase II, 1 Phase I, 1 Preclinical, 1 Preclinical, 1 Preclinical, 1 Preclinical, 2
Phase of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationMarketed
Autoimmune

2

1

1

3

1

2

Cancer

1

-

-

-

-

-

Inflammation

1

-

-

1

-

-

Neurology

1

-

-

-

-

-

Ophthalmic

-

-

1

-

-

-




 Products Targeting Interleukin-6 (IL-6) receptor (CD126)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$870.0M

$175.0M

$665.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today